Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

In light of major advances in immunoglobulin light chain (AL) amyloidosis, we evaluated the trends in presentation, management, and outcome among 1551 newly diagnosed AL amyloidosis patients seen in our institution from 2000 to 2014. As compared with the 2 intervals 2000-2004 and 2005-2009, patients...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Muchtar, Eli, Gertz, Morie A., Kumar, Shaji K., Lacy, Martha Q., Dingli, David, Buadi, Francis K., Grogan, Martha, Hayman, Suzanne R., Kapoor, Prashant, Leung, Nelson, Fonder, Amie, Hobbs, Miriam, Hwa, Yi Lisa, Gonsalves, Wilson, Warsame, Rahma, Kourelis, Taxiarchis V., Russell, Stephen, Lust, John A., Lin, Yi, Go, Ronald S., Zeldenrust, Steven, Kyle, Robert A., Rajkumar, S. Vincent, Dispenzieri, Angela
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2017
Sujets:
Clinical Trials and Observations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5391625/
https://ncbi.nlm.nih.gov/pubmed/28126928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-11-751628
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires